IL PROGETTO M-MASTER PER IL MASTER SUL RISCHIO IDRAULICO DELL'ATENEO DI FIRENZE

Il Progetto M-Master nasce da una collaborazione fra il Dipartimento di Ingegneria Civile dell'Università degli Studi Firenze e la Società Consortile E-Form. Il progetto è stato realizzato per alcuni master dell’Ateneo Fiorentino per promuovere una formazione di tipo “blended learning”. L’obiettivo è riuscire a rendere fruibili i master prevalentemente a distanza, integrando didattica, servizi di consulenza, fonti documentarie e bibliografiche e assistenza in presenza distribuita sul territorio nazionale. Nell’ambito del progetto M-Master si inserisce il master sul Rischio Idraulico proposto in risposta al crescente sviluppo di nuove metodologie e tecniche di indagine che richiedono di integrare l’attività di ricerca applicata con quella di formazione superiore favorendo l’accesso dei partecipanti ai laboratori e alle attrezzature scientifiche e utilizzando, per la divulgazione, le nuove opportunità offerte dalla tecnologia dell’informazione della formazione “e learning”. In tale contesto, basandosi sull’esperienza maturata nei 3 anni di attività, è stato dato avvio alla sperimentazione di una “biblioteca digitale aperta” sul rischio idraulico, strutturata come un ambiente virtuale a sostegno dell’apprendimento

Digital Modernism Heritage Lexicon

The book investigates the theme of Modernism (1920-1960 and its epigones) as an integral part of tangible and intangible cultural heritage which contains the result of a whole range of disciplines whose aim is to identify, document and preserve the memory of the past and the value of the future. Including several chapters, it contains research results relating to cultural heritage, more specifically Modernism, and current digital technologies. This makes it possible to record and evaluate the changes that both undergo: the first one, from a material point of view, the second one from the research point of view, which integrates the traditional approach with an innovative one. The purpose of the publication is to show the most recent studies on the modernist lexicon 100 years after its birth, moving through different fields of cultural heritage: from different forms of art to architecture, from design to engineering, from literature to history, representation and restoration. The book appeals to scholars and professionals who are involved in the process of understanding, reading and comprehension the transformation that the places have undergone within the period under examination. It will certainly foster the international exchange of knowledge that characterized Modernism

Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study

: The aims of this study is to evaluate the association between angiotensin-converting enzyme inhibitor (ACE-I), angiotensin II receptor blocker (ARBs) and/or statin use with the risk of pneumonia, as well as and with in-hospital and short-term outpatient mortality in hospitalized older patients with pneumonia. Patients aged 65 years or older hospitalized in internal medicine and/or geriatric wards throughout Italy and enrolled in the REPOSI (REgistro Politerapuie SIMI-Società Italiana di Medicina Interna) register from 2010 to 2019 were screened to assess the diagnosis of pneumonia and classified on whether or not they were prescribed with at least one drug among ACE-I, ARBs, and/or statins. Further study outcomes were mortality during hospital stay and at 3 months after hospital discharge. Among 5717 cases included (of whom 18.0% with pneumonia), 2915 (51.0%) were prescribed at least one drug among ACE-I, ARBs, and statins. An inverse association was found between treatment with ACE-I or ARBs and pneumonia (OR = 0.79, 95% CI 0.65-0.95). A higher effect was found among patients treated with ACE-I or ARBs in combination with statins (OR = 0.67, 95% CI 0.52-0.85). This study confirmed in the real-world setting that these largely used medications may reduce the risk of pneumonia in older people, who chronically take them for cardiovascular conditions